A new immunotherapy releases cancer-killing cytokines only within the tumor. Researchers at the University of California San Francisco (UCSF) have developed a new T cell-based immunotherapy that selectively targets cancer cells, producing a powerful anti-cancer cytokine specifically when it encount
Source: https://scitechdaily.com/supercharged-t-cells-a-new-way-to-kill-pancreatic-cancer-with-minimal-side-effects/